The deacetylase inhibitors—here to stay!

Por Prince, H. Miles
Publicado em 2010

Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect

Por Dickinson, Michael, Johnstone, Ricky W., Prince, H. Miles
Publicado em 2010

Efficacy of single-agent bortezomib vs. single-agent thalidomide in patients with relapsed or refractory multiple myeloma: a systematic comparison

Por Prince, H Miles, Adena, Michael, Smith, Dell Kingsford, Hertel, Judy
Publicado em 2007

Comment on “Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma”

Por Harrison, Simon J., Quach, Hang, Spencer, Andrew, Prince, H. Miles
Publicado no Haematologica (2015)

Update and new approaches in the treatment of Castleman disease

Por Chan, Kah-Lok, Lade, Stephen, Prince, H Miles, Harrison, Simon J
Publicado no J Blood Med (2016)

Durable remissions are rare following high dose therapy with autologous stem cell transplantation for adults with "paediatric" bone and soft tissue sarcomas

Por Nath, Shriram V, Prince, H Miles, Choong, Peter FM, Toner, Guy C
Publicado em 2005

Effusion-associated anaplastic large cell lymphoma of the breast: time for it to be defined as a distinct clinico-pathological entity

Por Thompson, Philip A., Lade, Stephen, Webster, Howard, Ryan, Gail, Prince, H. Miles
Publicado em 2010

Overview of Histone Deacetylase Inhibitors in Haematological Malignancies

Por Bishton, Mark J., Johnstone, Ricky W., Dickinson, Michael, Harrison, Simon, Prince, H. Miles
Publicado em 2010

Denileukin diftitox for the treatment of CD25 low-expression mycosis fungoides and Sézary syndrome

Por Prince, H. Miles, Martin, Ann G., Olsen, Elise A., Fivenson, David P., Duvic, Madeleine
Publicado em 2013

Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial

Por Foss, Francine, Horwitz, Steven, Pro, Barbara, Prince, H. Miles, Sokol, Lubomir, Balser, Barbara, Wolfson, Julie, Coiffier, Bertrand
Publicado no J Hematol Oncol (2016)

Breast Implant-Associated, ALK-Negative, T-Cell, Anaplastic, Large-Cell Lymphoma: Establishment and Characterization of a Model Cell Line (TLBR-1) for This Newly Emerging Clinical...

Por Lechner, Melissa G., Lade, Stephen, Liebertz, Daniel J., Prince, H. Miles, Brody, Garry S., Webster, Howard R., Epstein, Alan L.
Publicado em 2010

CAR-T cells are serial killers

Por Davenport, Alexander J, Jenkins, Misty R, Ritchie, David S, Prince, H Miles, Trapani, Joseph A, Kershaw, Michael H, Darcy, Phillip K, Neeson, Paul J
Publicado no Oncoimmunology (2015)

Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report

Por Ritchie, David, Piekarz, Richard L., Blombery, Piers, Karai, Laszlo J., Pittaluga, Stefania, Jaffe, Elaine S., Raffeld, Mark, Janik, John E., Prince, H. Miles, Bates, Susan E.
Publicado em 2009

Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma

Por Blombery, Piers, Thompson, Ella R., Jones, Kate, Arnau, Gisela Mir, Lade, Stephen, Markham, John F., Li, Jason, Deva, Anand, Johnstone, Ricky W., Khot, Amit, Prince, H. Miles, Westerman, David
Publicado no Haematologica (2016)

Induction of Multi-Functional T Cells in a Phase I Clinical Trial of Dendritic Cell Immunotherapy in Hepatitis C Virus Infected Individuals

Por Li, Shuo, Roberts, Stuart, Plebanski, Magdalena, Gouillou, Maelenn, Spelman, Tim, Latour, Philippe, Jackson, David, Brown, Lorena, Sparrow, Rosemary L., Prince, H. Miles, Hart, Derek, Loveland, Bruce E., Gowans, Eric J.
Publicado em 2012

Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma

Por Foss, Francine, Coiffier, Bertrand, Horwitz, Steven, Pro, Barbara, Prince, H Miles, Sokol, Lubomir, Greenwood, Matthew, Lerner, Adam, Caballero, Dolores, Baran, Eugeniusz, Kim, Ellen, Nichols, Jean, Balser, Barbara, Wolfson, Julie, Whittaker, Sean
Publicado em 2014

Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses

Por Coiffier, Bertrand, Pro, Barbara, Prince, H Miles, Foss, Francine, Sokol, Lubomir, Greenwood, Matthew, Caballero, Dolores, Morschhauser, Franck, Wilhelm, Martin, Pinter-Brown, Lauren, Padmanabhan Iyer, Swaminathan, Shustov, Andrei, Nielsen, Tina, Nichols, Jean, Wolfson, Julie, Balser, Barbara, Horwitz, Steven
Publicado em 2014

Adoptive transfer of T cells modified with a humanized chimeric receptor gene inhibits growth of Lewis-Y-expressing tumors in mice

Por Westwood, Jennifer A., Smyth, Mark J., Teng, Michele W. L., Moeller, Maria, Trapani, Joseph A., Scott, Andrew M., Smyth, Fiona E., Cartwright, Glenn A., Power, Barbara E., Hönemann, Dirk, Prince, H. Miles, Darcy, Phillip K., Kershaw, Michael H.
Publicado em 2005

No adverse safety or virological changes two years following vorinostat in HIV-infected individuals on antiretroviral therapy

Por MOTA, Talia M, RASMUSSEN, Thomas A, RHODES, Ajantha, TENNAKOON, Surekha, DANTANARAYANA, Ashanti, WIGHTMAN, Fiona, HAGENAUER, Michelle, RONEY, Janine, SPELMAN, Tim, PURCELL, Damian FJ, McMAHON, James, HOY, Jennifer F, PRINCE, H. Miles, ELLIOTT, Julian H, LEWIN, Sharon R
Publicado no AIDS (2017)

Extracorporeal Photopheresis for the Prevention of Acute GVHD in Patients Undergoing Standard Myeloablative Conditioning and Allogeneic Hematopoietic Stem Cell Transplantation

Por Shaughnessy, Paul J, Bolwell, Brian J, van Besien, Koen, Mistrik, Martin, Grigg, Andrew, Dodds, Anthony, Prince, H Miles, Durrant, Simon, Ilhan, Osman, Parenti, Dennis, Rogers, Jon, Gallo, Jose, Foss, Francine, Apperley, Jane, Zhang, Mei-Jie, Horowitz, Mary M, Abhyankar, Sunil
Publicado em 2009